Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133999) titled 'Dual-Targeted Combined Intervention in High-Risk HBV-Related Hepatocellular Carcinoma: An Observational Study' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
Condition:
Chronic Hepatitis B?HBV-related Hepatocellular Carcinoma?HBV-related Compensated Liver Cirrhosis
Intervention:
Pegylated Interferon a-2b Combined/Monotherapy Group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-16
Target Sample Size: Pegylated Interferon a-2b Combined/Monotherapy Group:600;Nucleos(t)ide A...